Precision radiation aims to stall prostate cancer spread
NCT ID NCT04983095
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding precise, high-dose radiation (SBRT) to standard hormone therapy can delay cancer progression in men with prostate cancer that has spread to 1-3 spots. About 118 participants will be randomly assigned to get SBRT plus standard care or standard care alone. The goal is to see if the radiation helps keep the cancer from growing longer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stereotactic body radiotherapy (SBRT) plus standard hormone therapy
- What this could lead to
- If it works, this could improve control of prostate cancer that has spread to a few spots, delaying the need for stronger treatments.
- What could go wrong
- This is a phase III trial but still early in recruitment. The benefit may be small, and radiation can cause side effects like fatigue or local irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HORMONE SENSITIVE PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Capio St Göran Hospital
RECRUITINGStockholm, Region Stockholm, Sweden
-
Karolinska University Hospital
RECRUITINGStockholm, Stockholm County, Sweden
-
Region Skåne
RECRUITINGLund, Lund, Sweden
-
Region Örebro Län
RECRUITINGÖrebro, Örebro County, Sweden
-
Ryhovs county hospital
RECRUITINGJönköping, Sweden
-
Södersjukhuset
RECRUITINGStockholm, Region Stockholm, Sweden
-
Umeå University hospital
RECRUITINGUmeå, Umea, 90331, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill outsmart resistant prostate cancer?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?
- Could a chemo boost after radiation tame aggressive prostate cancer?
- New scan could replace risky vein test for Hormone-Driven high blood pressure
- New imaging agent could sharpen cancer detection
- Smartphone app aims to capture cancer patients' diets during radiation